Three patients who presented with parkinsonian signs resulting from a focal
midbrain lesion are reported. In all patients parkinsonian features occurr
ed acutely and improved following acute challenge with apomorphine but not
with levodopa. Remission of parkinsonian signs occurred spontaneously to a
different degree. Inconsistent clinical response following administration o
f levodopa has been well documented in patients with focal midbrain lesions
associated with parkinsonian signs; however, the efficacy of apomorphine h
as not been tested before. Anatomic or etiologic features do not allow us t
o predict in which cases parkinsonian signs secondary to a midbrain lesion
would respond to levodopa or to dopamine agonists. A trial with apomorphine
is warranted in all such cases.